Startup entity
funding is the sole category represented across all 1 tracked stories. Russ Lebovitz is most often covered alongside Amprion, Inc., which appears in 1 of these 1 story. We currently track 1 Startup story that mention Russ Lebovitz, all published on July 27, 2026.
Last mentioned: Jul 27, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
funding is the sole category represented across all 1 tracked stories. Russ Lebovitz is most often covered alongside Amprion, Inc., which appears in 1 of these 1 story. We currently track 1 Startup story that mention Russ Lebovitz, all published on July 27, 2026. Each carries 1 original source on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Russ Lebovitz. Shared-story counts are live from our verified record — not editorial picks.
Amprion closed a multi-million-dollar revenue-based funding round from Decathlon Capital Partners to scale its seed-amplification testing for Parkinson’s and Alzheimer’s. The non-dilutive structure lets the diagnostics startup preserve equity while meeting surging clinical demand—a financing model that savvy founders increasingly favor.
Source: prnewswire.com
Russ Lebovitz is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
